• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估头颈癌患者1年、5年和10年时与口腔和牙齿健康相关的生活质量:欧洲癌症研究与治疗组织QLQ43、FACT H&N和正颌QLQ问卷的比较

Assessing oral and dental health-related quality of life in head and neck cancer patients at 1, 5, and 10 years: a comparison of the EORTC QLQ43, FACT H&N, and the Orthognathic-QLQ questionnaires.

作者信息

Guedea Marc, Sánchez Meritxell, Lozano Alicia, Ferrer Montse, Pont Angels, Clotet Sandra, Juárez Marc, Linares Isabel, Araguas Pablo, Ventura Montse, d'Oliveira Nuno Gustavo, Manzanares Maria Cristina, Ustrell Josep Maria, Guedea Ferran

机构信息

Orthodontics Department. Facultat de Medicina I Ciències de la Salut, University of Barcelona (UB), Barcelona, Spain.

Radiation Oncology Department, Institut Català d'Oncologia (ICO), Hospital Duran I Reynals, L'Hospitalet de Llobregat, Barcelona, Spain.

出版信息

Clin Transl Oncol. 2025 Apr 10. doi: 10.1007/s12094-025-03895-0.

DOI:10.1007/s12094-025-03895-0
PMID:40208518
Abstract

PURPOSE

Numerous health-related quality of life (HRQoL) questionnaires are available to assess oral HRQoL in patients undergoing treatment for head and neck (H&N) cancer. These multidimensional instruments should have the capacity to detect meaningful clinical oral function/dental changes at different time points. However, the optimal instrument-or combination of instruments-for assessing oral health and dental needs is not clear. We administered three questionnaires (FACT H&N, EORTC QLQ-H&N43, Orthognathic-QLQ) to assess oral and dental HRQoL in a cohort of H&N cancer patients at 1-, 5- and 10-year post-treatment. A secondary aim was to compare these questionnaires to determine which provides the most useful assessment of oral HRQoL and dental care needs.

METHODS

Prospective, single-center study of patients (n = 82) with H&N cancer grouped according to the follow-up time (1, 5, or 10 years). HRQoL was assessed by telephone with the Functional Assessment of Cancer Therapy (FACT H&N), the European Organization for Research and Treatment (EORTC QLQ-H&N43), and the Orthognathic Questionnaire (OQLQ). Analyses were performed to assess differences between groups.

RESULTS

Eighty-two patients (fifty-nine men) were included. The mean age was 61.9 years. On the EORTC QLQ-H&N43, significant between-group differences (1 year vs. 5 and 10 years) were observed on five multi-item scales (mouth pain, senses, body image, anxiety, and shoulder problems) and on three single-item scales (neurological problems, neck swelling, and weight loss), indicating that QoL for those domains was more negatively impacted at 1-year post-treatment. Adjusted mean scores on most items on the EORTC QLQ-H&N43 were similar in the 5- and 10-year groups. On the other two scales (FACT H&N and OQLG), there were no significant between-group (1, 5, 10 years) differences in adjusted mean scores.

CONCLUSION

These results show that the negative impact of H&N cancer on HRQoL is most evident at 1-year versus 5- or 10-year post-treatment. The combined administration of the EORTC QLQ-H&N43 and the OQLQ appear to provide the most useful assessment of HRQoL.

摘要

目的

有许多与健康相关的生活质量(HRQoL)问卷可用于评估接受头颈部(H&N)癌症治疗患者的口腔HRQoL。这些多维度工具应具备在不同时间点检测有意义的临床口腔功能/牙齿变化的能力。然而,用于评估口腔健康和牙齿需求的最佳工具或工具组合尚不清楚。我们发放了三份问卷(FACT H&N、EORTC QLQ-H&N43、正颌QLQ),以评估一组H&N癌症患者在治疗后1年、5年和10年时的口腔和牙齿HRQoL。第二个目的是比较这些问卷,以确定哪一份问卷能最有效地评估口腔HRQoL和牙齿护理需求。

方法

对H&N癌症患者(n = 82)进行前瞻性单中心研究,根据随访时间(1年、5年或10年)分组。通过电话使用癌症治疗功能评估量表(FACT H&N)、欧洲癌症研究与治疗组织量表(EORTC QLQ-H&N43)和正颌问卷(OQLQ)对HRQoL进行评估。进行分析以评估组间差异。

结果

纳入82例患者(59例男性)。平均年龄为61.9岁。在EORTC QLQ-H&N43量表上,在五个多项目量表(口腔疼痛、感觉、身体形象、焦虑和肩部问题)和三个单项目量表(神经问题颈部肿胀和体重减轻)上观察到显著的组间差异(1年与5年和10年相比),表明这些领域的生活质量在治疗后1年受到的负面影响更大。EORTC QLQ-H&N43量表上大多数项目的调整后平均得分在5年组和10年组中相似。在其他两个量表(FACT H&N和OQLG)上,调整后平均得分在组间(1年、5年、10年)无显著差异。

结论

这些结果表明,H&N癌症对HRQoL的负面影响在治疗后1年比5年或10年时最为明显。联合使用EORTC QLQ-H&N43量表和OQLQ量表似乎能最有效地评估HRQoL。

相似文献

1
Assessing oral and dental health-related quality of life in head and neck cancer patients at 1, 5, and 10 years: a comparison of the EORTC QLQ43, FACT H&N, and the Orthognathic-QLQ questionnaires.评估头颈癌患者1年、5年和10年时与口腔和牙齿健康相关的生活质量:欧洲癌症研究与治疗组织QLQ43、FACT H&N和正颌QLQ问卷的比较
Clin Transl Oncol. 2025 Apr 10. doi: 10.1007/s12094-025-03895-0.
2
Reliability of the electronic patient reported outcome measures for assessing xerostomia, dysphagia and quality of life in Spanish patients with head and neck cancer: a randomised crossover design.用于评估西班牙头颈癌患者口干、吞咽困难和生活质量的电子患者报告结局指标的可靠性:一项随机交叉设计。
Health Qual Life Outcomes. 2025 Mar 3;23(1):19. doi: 10.1186/s12955-025-02347-1.
3
The EORTC QLQ43 and FACT H&N questionnaires of quality of life at 1 and 5 years after treatment and dental care in head and neck cancer patients: a pilot study.头颈部癌症患者治疗及牙科护理后1年和5年的生活质量:EORTC QLQ43和FACT H&N问卷的一项初步研究
Clin Transl Oncol. 2025 Jan;27(1):166-174. doi: 10.1007/s12094-024-03567-5. Epub 2024 Jun 23.
4
Psychometric Properties of the European Organization for Research and Treatment of Cancer Head and Neck (EORTC QLQ H&N 43) Quality of Life Tool for Use in the Eastern India Population.欧洲癌症研究与治疗组织头颈部(EORTC QLQ H&N 43)生活质量工具在印度东部人群中的心理测量特性。
Indian J Otolaryngol Head Neck Surg. 2025 Jul;77(7):2523-2534. doi: 10.1007/s12070-025-05549-7. Epub 2025 May 16.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Patient-reported outcomes with belantamab mafodotin, bortezomib, and dexamethasone versus daratumumab, bortezomib, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): results from a phase 3, open-label, randomised controlled trial.复发或难治性多发性骨髓瘤患者中,贝兰他单抗马福多汀、硼替佐米与地塞米松联合用药对比达雷妥尤单抗、硼替佐米与地塞米松联合用药的患者报告结局(DREAMM-7):一项3期、开放标签、随机对照试验的结果
Lancet Haematol. 2025 Jul 15. doi: 10.1016/S2352-3026(25)00163-2.
7
Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT.功能性运动障碍专科物理治疗的效果:Physio4FMD随机对照试验
Health Technol Assess. 2025 Jul;29(34):1-28. doi: 10.3310/MKAC9495.
8
Psychosocial interventions for patients with head and neck cancer.头颈部癌症患者的心理社会干预措施。
Cochrane Database Syst Rev. 2013 Jul 16;2013(7):CD009441. doi: 10.1002/14651858.CD009441.pub2.
9
Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change.评估妇科肿瘤学中的健康相关生活质量:问卷及其检测临床重要差异和变化能力的系统评价。
Int J Gynecol Cancer. 2010 May;20(4):664-84. doi: 10.1111/IGC.0b013e3181dad379.
10
Exercise interventions on health-related quality of life for people with cancer during active treatment.积极治疗期间针对癌症患者健康相关生活质量的运动干预措施。
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2.

本文引用的文献

1
The EORTC QLQ43 and FACT H&N questionnaires of quality of life at 1 and 5 years after treatment and dental care in head and neck cancer patients: a pilot study.头颈部癌症患者治疗及牙科护理后1年和5年的生活质量:EORTC QLQ43和FACT H&N问卷的一项初步研究
Clin Transl Oncol. 2025 Jan;27(1):166-174. doi: 10.1007/s12094-024-03567-5. Epub 2024 Jun 23.
2
Oral-Functioning Questionnaires in Patients with Head and Neck Cancer: A Scoping Review.头颈部癌患者的口腔功能问卷:一项范围综述
J Clin Med. 2023 Jun 10;12(12):3964. doi: 10.3390/jcm12123964.
3
Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors.
颌骨放射性骨坏死综述:放疗方式、技术及剂量作为风险因素
J Clin Med. 2023 Apr 21;12(8):3025. doi: 10.3390/jcm12083025.
4
The role of primary dental care practitioners in the long-term management of patients treated for head and neck cancer.初级牙科保健医生在头颈部癌症治疗患者的长期管理中的作用。
Br Dent J. 2022 Nov;233(9):765-768. doi: 10.1038/s41415-022-5148-z. Epub 2022 Nov 11.
5
Oral health related quality of life in long-term survivors of head and neck cancer compared to a general population from the seventh Tromsø study.头颈部癌症长期幸存者的口腔健康相关生活质量与第七次特罗姆瑟研究中的一般人群相比。
BMC Oral Health. 2022 Mar 30;22(1):100. doi: 10.1186/s12903-022-02140-2.
6
Head and neck cancer.头颈部癌症。
Lancet. 2021 Dec 18;398(10318):2289-2299. doi: 10.1016/S0140-6736(21)01550-6. Epub 2021 Sep 22.
7
Equivalence testing of a newly developed interviewer-led telephone script for the EORTC QLQ-C30.新开发的由调查员主导的电话脚本的 EORTC QLQ-C30 等效性测试。
Qual Life Res. 2022 Mar;31(3):877-888. doi: 10.1007/s11136-021-02955-6. Epub 2021 Jul 20.
8
SEOM clinical guidelines for the treatment of head and neck cancer (2020).头颈部肿瘤治疗的 SEOM 临床指南(2020)。
Clin Transl Oncol. 2021 May;23(5):913-921. doi: 10.1007/s12094-020-02533-1. Epub 2021 Feb 26.
9
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
10
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.MASCC/ISOO 临床实践指南:癌症治疗相关黏膜炎的管理。
Cancer. 2020 Oct 1;126(19):4423-4431. doi: 10.1002/cncr.33100. Epub 2020 Jul 28.